Literature DB >> 26235571

Cell Death in the Cardiac Myocyte.

Tetsuro Marunouchi1, Kouichi Tanonaka.   

Abstract

Loss of cardiac myocytes plays a critical role in the pathogenesis of cardiovascular disorders. A decrease in the number of cardiac myocytes in cardiac diseases results in sustained, irreversible contractile failure of myocardium. Therefore prevention of cardiac cell death is a potential therapeutic strategy for various heart diseases. It is well accepted that three types of phenomena such as apoptosis, necrosis, and autophagy may be involved in myocardial cell death. Apoptosis is a highly regulated process that is promoted via death receptor pathway in the plasma membrane or via mitochondrial pathway. Necrosis is induced via mitochondrial swelling, cell rupture, and subsequent inflammation. Autophagy is a cell survival mechanism that involves degradation and recycling of cytoplasmic components. As compared with the other two mechanisms, autophagy may mediate cell death under specific conditions. These three types of cell death in the myocardium are discussed in this article.

Entities:  

Mesh:

Year:  2015        PMID: 26235571     DOI: 10.1248/bpb.b15-00288

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  19 in total

1.  VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.

Authors:  Hadar Klapper-Goldstein; Ankit Verma; Sigal Elyagon; Roni Gillis; Michael Murninkas; Srinivas Pittala; Avijit Paul; Varda Shoshan-Barmatz; Yoram Etzion
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

2.  Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.

Authors:  Danya Ben-Hail; Racheli Begas-Shvartz; Moran Shalev; Anna Shteinfer-Kuzmine; Arie Gruzman; Simona Reina; Vito De Pinto; Varda Shoshan-Barmatz
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

3.  Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling.

Authors:  Megan T Quintana; Traci L Parry; Jun He; Cecelia C Yates; Tatiana N Sidorova; Katherine T Murray; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Samuel C Eaton; Akinori Hishiya; Shin Takayama; Monte S Willis
Journal:  Am J Pathol       Date:  2016-06-17       Impact factor: 4.307

4.  Protective effects of carnosic acid against mitochondria-mediated injury in H9c2 cardiomyocytes induced by hypoxia/reoxygenation.

Authors:  Ping Liu; Jing Dong
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

5.  [Mibefradil improves skeletal muscle mass, function and structure in obese mice].

Authors:  J Wu; Y Wu; Y Yang; J Yu; R Fu; Y Sun; Q Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-07-20

6.  The FGF-AKT pathway is necessary for cardiomyocyte survival for heart regeneration in zebrafish.

Authors:  Naoyuki Tahara; Ryutaro Akiyama; Justin Wang; Hiroko Kawakami; Yasumasa Bessho; Yasuhiko Kawakami
Journal:  Dev Biol       Date:  2021-01-11       Impact factor: 3.582

7.  A HSP60-targeting peptide for cell apoptosis imaging.

Authors:  S Yang; J Meng; Y Yang; H Liu; C Wang; J Liu; Y Zhang; C Wang; H Xu
Journal:  Oncogenesis       Date:  2016-02-29       Impact factor: 7.485

Review 8.  Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Authors:  Varda Shoshan-Barmatz; Yakov Krelin; Anna Shteinfer-Kuzmine; Tasleem Arif
Journal:  Front Oncol       Date:  2017-07-31       Impact factor: 6.244

Review 9.  The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (Review).

Authors:  Emmanuel Papadakis; Meletios Kanakis; Agapi Kataki; Demetrios A Spandidos
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

10.  Macrophages induce the expression of lncRNA ATB via the secretion of TGF-β to relieve ischemia-reperfusion injury in cardiomyocytes.

Authors:  Hong Lin; Wen-Sheng Xu; Xiong-Wei Liu; Zhi Wang; Jiao Yan; Tao Zhang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.